Related Experiment Video
Updated: Jun 5, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
[Minodronic acid- its clinical efficacy and prospects for once-a-month dosing regimen]
1School of Health Science, Tottori University and Rehabilitation Division, Tottori University Hospial.
Abstract:
Minodronic acid has been developed and approved for the treatment of osteoporosis in Japan. It was reported that daily 1 mg minodronate for 24 months reduced the risk of vertebral fractures. It was also reported that minodronic acid suppressed the risk of vertebral fractures in patients aged 75 years or older in the same way as in patients aged less than 75 years. Monthly 50 mg minodronate is now under development for the treatment of osteoporosis in Japan. It is expected that monthly administration would improve medication adherence and, as a result, incidence of fragility fractures will be reduced with the improvement of quality of life in the elderly.
Related Concept Videos
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Therapy
Antianxiety Medications
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
